Toot

Written by Christos Argyropoulos MD PhD on 2025-02-06 at 19:06

Invivyd Announces Positive Phase 1/2 Clinical Data for VYD2311, a Monoclonal Antibody Designed to be a Superior Alternative to COVID-19 Vaccination for the Broad Population | NASDAQ https://www.nasdaq.com/press-release/invivyd-announces-positive-phase-1-2-clinical-data-vyd2311-monoclonal-antibody

😎

=> More informations about this toot | View the thread | More toots from ChristosArgyrop@mastodon.social

Mentions

Tags

Proxy Information
Original URL
gemini://mastogem.picasoft.net/toot/113958506016073644
Status Code
Success (20)
Meta
text/gemini
Capsule Response Time
224.047944 milliseconds
Gemini-to-HTML Time
0.321777 milliseconds

This content has been proxied by September (3851b).